TABLE 3.
Treatment-related adverse events
| Treatment-related adverse events | Any grade; n (%) | Grade 1/2; n (%) | Grade 3/4; n (%) |
|---|---|---|---|
| All adverse events | 61 (100) | 61 (100) | 17 (28) |
| Elevated AST level | 54 (89) | 39 (64) | 16 (26) |
| Hypoalbuminemia | 46 (75) | 46 (75) | 0 |
| Elevated ALT level | 45 (74) | 37 (61) | 8 (13) |
| Anemia | 34 (56) | 33 (54) | 1 (2) |
| Weight loss | 33 (54) | 33 (54) | 0 |
| Fatigue | 32 (52) | 32 (52) | 0 |
| Pain | 29 (48) | 28 (46) | 1 (2) |
| Hypokalemia | 22 (36) | 20 (33) | 2 (3) |
| Nausea | 22 (36) | 21 (34) | 1 (2) |
| Dry mouth | 20 (33) | 20 (33) | 0 |
| Fever | 18 (30) | 18 (30) | 0 |
| Hyperbilirubinemia | 18 (30) | 18 (30) | 0 |
| Rash | 15 (25) | 15 (25) | 0 |
| Dyspepsia | 15 (25) | 15 (25) | 0 |
| Oral mucositis | 13 (21) | 12 (20) | 1 (2) |
| Constipation | 12 (20) | 12 (20) | 0 |
| Leukocytopenia | 9 (15) | 9 (15) | 0 |
| Thrombocytopenia | 9 (15) | 9 (15) | 0 |
| Dry skin | 8 (13) | 8 (13) | 0 |
| Infusion-related reaction | 7 (11) | 7 (11) | 0 |
| Neutropenia | 6 (10) | 5 (8) | 1 (2) |
| Diarrhea | 5 (8) | 5 (8) | 0 |
| Vomiting | 5 (8) | 5 (8) | 0 |
Abbreviations: ALT indicates alanine aminotransferase; AST, aspartate aminotransferase.